Strong prospects for Novartis cancer drug, say analysts

April 24, 2009
Research and Development, Sales and Marketing Afinitor, Novartis

The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …

GSK freezes prices in Germany as part of PR trail

April 24, 2009
Sales and Marketing GSK, Germany

GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …

Merck Serono launches Kuvan in Europe

April 24, 2009
Sales and Marketing Kuvan, Merck Serono, PKU

Kuvan, the first treatment for two rare neurological disorders, has been launched in the UK, France and Germany.Merck Serono’s drug …

Pharma welcomes UK taxation pledge

April 23, 2009
ABPI

The UK government budget delivered in the gloom of the recession has provided good news for the industry, according to …

Sanofi-Aventis commits 100 million euros to Chinese expansion

April 23, 2009
Research and Development Asia, China, Sanofi-Aventis

France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …

NICE approves Bayer’s Xarelto

April 23, 2009
Research and Development Bayer, NICE, Xarelto

NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …

Pharma-NHS joint working

April 22, 2009
Research and Development, Sales and Marketing ABPI, doctors, industry relations

An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …

GSK launches Alli in Europe

April 22, 2009
Sales and Marketing Alli, Europe, GSK

GSK has launched Alli, making it the first clinically proven over-the-counter weight loss aid to be available in pharmacies across …

Deal brings single ASEAN pharma market closer

April 22, 2009
Manufacturing and Production Asia

An accord signed by economic ministers of the Association of Southeast Asian Nations, aimed at bringing manufacturing standards into line, …

Little benefit to pharma from G20 initiatives

April 22, 2009
Research and Development, Sales and Marketing Datamonitor, strategy

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …

AZ shuns mega-mergers but still open to smaller deals

April 21, 2009
Research and Development, Sales and Marketing AZ

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …

Is the UK falling behind in clinical trials?

April 21, 2009
Research and Development NHS

New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …

GSK buys Stiefel for $3.6bn

April 20, 2009
Research and Development, Sales and Marketing GSK, MA

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …

Sanofi manufacturing plant closed by Italian earthquake

April 17, 2009
Manufacturing and Production Europe, Italy, Sanofi-Aventis

A manufacturing facility operated by Sanofi-Aventis in Abruzzo, Italy, remains closed following the earthquake that claimed more than 280 lives …

GSK and Pfizer to create HIV joint venture company

April 16, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …

Amgen cuts back at US pilot plant

April 16, 2009
Manufacturing and Production Amgen

The worlds largest biotech company, Amgen, is cutting 100 staff at its production facility in Bothell, Washington, as part of …

Merck acquires rights to atrial fibrillation candidate

April 16, 2009
Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …

The Gateway to Local Adoption Series

Latest content